Surgeries & Interventions March 27, 2023
Ancora Heart’s AccuCinch TLVR HF Improvements March 27, 2023
New data suggests that Ancora Heart’s investigational AccuCinch Transcatheter Left Ventricular Restoration (TLVR) system improves heart failure patients’ cardiac structure, quality of life, and function.
Preventive Cardiology March 23, 2023
Small Cardiorespiratory Fitness Changes, Big Mortality Impact March 23, 2023
A new JACC study highlighted the massive impact cardiorespiratory fitness has on mortality risks, including even small fitness changes.
Cardiology Business March 20, 2023
Esperion and Daiichi Sankyo’s Milestone Faceoff March 20, 2023
Esperion and Daiichi Sankyo went from partners to adversaries, after Daiichi revealed that it doesn't plan on paying Esperion the up to $440M in milestone payments associated with its bempedoic acid cholesterol drug.
Cardiovascular Disease March 16, 2023
Inflammation’s ASCVD Risks and Potential March 16, 2023
New data reveals that inflammation is a stronger predictor of future cardiovascular events and death than cholesterol among patients who take statins, suggesting that treatment regimens that target both LDL and vascular inflammation are more likely to reduce atherosclerotic risk.
Population Health March 13, 2023
Young Adult Risks Factors Predict CVD Tsunami March 13, 2023
Among all the ACC presentations that addressed cardiovascular disease prevention, one particularly alarming study underscored how crucial those preventative actions might be if we’re going to avoid a “tsunami of cardiovascular disease over the long-term.”
Cardiology March 9, 2023
Cardiac Wire’s Top 8 Takeaways from ACC 2023 March 9, 2023
ACC 2023 is officially a wrap, and it was by far cardiology’s biggest event in three years. In this story we detail Cardiac Wire’s top eight takeaways from ACC 2023.
Cardiovascular Disease March 6, 2023
FOURIER-OLE Shows Benefits of Reducing LDL-C Levels March 6, 2023
How low can you go? The lower the better, at least when it comes to low-density lipoprotein cholesterol (LDL-C). That’s according to new findings from the FOURIER-OLE study, which found the lowest rates of cardiovascular disease among individuals with the lowest LDL-C levels.
Artificial Intelligence March 2, 2023
Creating A Novice Heart Failure Screening Pathway March 2, 2023
We hear a lot about AI’s potential to expand echocardiography to far more users and clinical settings, and a new study out of Singapore suggests that echo’s AI-driven expansion might go far beyond what many of us had in mind.
Cardiovascular Disease February 27, 2023
LDL-TG’s Atherosclerosis Association February 27, 2023
Out of tens of thousands of blood-based molecules and biomarkers, triglyceride-rich LDL molecules emerged as a direct cause of atherosclerotic coronary artery disease
Cardiovascular Disease February 21, 2023
Uncovering the Long-Term CV Risks Following Pregnancy Complications February 21, 2023
Long-term risks of pregnancy complications often go unmentioned between women and their physicians in routine practice. But this study reveals that adverse pregnancy outcomes are important lifelong risk factors for heart disease, and provide an opportunity to identify high-risk women earlier than with traditional risk factors alone.
Cardiology Business February 16, 2023
GE HealthCare Adds Echo Guidance with Caption Health Acquisition February 16, 2023
GE HealthCare took a major step towards expanding echo ultrasound exams to new users and settings, acquiring AI guidance startup Caption Health.
Cardiology Business February 13, 2023
Biosense Webster’s PFA Milestone February 13, 2023
J&J’s Biosense Webster subsidiary is making strides toward the completion of its pulsed field ablation (PFA) clinical trial, joining competitors Medtronic and Boston Scientific in the race for FDA approval.
Cardiovascular Disease Solutions February 9, 2023
Challenging the HFpEF Treatment Dogma February 9, 2023
The landmark myPACE trial found that patients with HFpEF who have their pacemakers’ set to a higher backup resting heart rate reaped important health benefits. The findings challenge the long-standing belief among cardiologists that patients with HFpEF and diastolic dysfunction benefit from lower heart rates.
Cardiogenetics February 6, 2023
The Power of Low Lifelong LDL-C February 6, 2023
A high-impact genetic association study found that people with certain genetic variants were 50% less likely to develop coronary heart disease. The findings reveal the importance of maintaining low LDL-C (or “bad” cholesterol) levels over a lifetime.
Cardiac Imaging February 2, 2023
Echo AI Model for CAC Scoring February 2, 2023
A Cedars-Sinai-led team developed an echocardiography AI model that accurately assessed coronary artery calcium buildup, potentially revealing a safer, more economical, and more accessible approach to CAC scoring.
Surgeries & Interventions January 30, 2023
AVS Raises $20M for Calcified Arterial Disease January 30, 2023
Medical device startup AVS recently closed $20M in Series B funding to advance novel treatments for severely calcified arterial disease.
Artificial Intelligence January 26, 2023
Triaging Acute Chest Pain with Chest X-Ray AI January 26, 2023
Patients who arrive at the ED with acute chest pain (ACP) syndrome end up receiving a series of often-negative tests, but a new MGB-led study suggests that incorporating AI-based chest X-ray (CXR) analysis might make ACP triage more accurate and efficient.
Cardiovascular Disease Solutions January 23, 2023
Six-Year Study Sheds Light on Intermittent Fasting January 23, 2023
Does the timing of when one consumes their meals really matter, or is it merely the fact that eating within a tighter window encourages reduced caloric intake?
Surgeries & Interventions January 19, 2023
CAPLA: Simple Ablation is Best January 19, 2023
There is a tendency to think “more is better” when dealing with persistent AFib. This study adds to a growing body of evidence challenging that mindset.
